Health Condition 1: null- Patients with a neurosurgical condition (either head trauma or post-neurosurgery)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. A neurosurgical patient with a traumatic intracranial hematoma that is conservatively managed but is considered to have risk for expansion and clinical deterioration. The head trauma should have occurred within two hours of admission. 2. A post-operative neurosurgical patient who has undergone removal of a brain tumor in the immediate postoperative period Only two carefully selected patients are planned for this study as this is an early exploratory study to assess the feasibility of a well-known imaging modality for a particular clinical situation.
Exclusion criteria
Exclusion criteria: 1. A patient who is disoriented or unconscious and is likely not to cooperate with instructions in the imaging gantry 2. A patient on ventilator support. 3. A patient with injuries to limbs or other major organs which require management. 4. Patient with a focal neurological deficit which prevents him from understanding instructions or is unable to communicate while he is on the MR gantry 5. A patient who has a contraindication for MR imaging like a patient with a metal implant or a patient with claustrophobia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (a) Overall (specific objective) : To study the technical feasibility of continuously or near continuously imaging the brain using magnetic resonance imaging in neurosurgical patients. Secondary objectives: 1. To study the imaging data set acquired to find the changes that occur during the monitoring period 2. The most efficient MR sequence that will be useful in this setting 3. The man power requirements and costs of such an imaging technique Timepoint: Imaging and other data will be acquired throughout the six hour duration of the trial for each of the two patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objectives: 1. To study the imaging data set acquired to find the changes that occur during the monitoring period 2. The most efficient MR sequence that will be useful in this setting 3. The man power requirements and costs of such an imaging technique Timepoint: Imaging and other data will be acquired throughout the six hour duration of the trial for each of the two patients. | — |
Countries
India
Contacts
Jawaharlal Institute of Post-graduate Medical Education and Research